Preclinical and epidemiologic evidence linking air pollution to cardio-oncology.
Silo Pharma’s SPU-21 Peptide Shows Positive Results Against Rheumatoid Arthritis | Psychedelic Invest
–Human tissue study assessed SPU-21’s efficiency, optimization, and binding affinity– Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics
October 16, 2023